Nổi bật :
MaxCyte Establishes New Scientific Advisory Board Comprised
MaxCyte’s Scientific Advisory Board will provide guidance to shape the technical direction of the company’s innovation initiatives focused on the...
Ebix Hosts Q4 Investor Call Wednesday, March 15, 2023 at
JOHNS CREEK, Ga., March 07, 2023 (GLOBE NEWSWIRE) -- Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of on-demand software and e-commerce...
Wish to Participate in Loop Capital Markets 2023 Virtual
SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH), one of the world’s largest mobile ecommerce platforms,...
Additional Data on Lumos OraGrowtH Trials Presented
Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data Analysis Baseline Characteristics...
GDS to Report Fourth Quarter and Full Year 2022 Financial
SHANGHAI, China, March 05, 2023 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading...
Cytokinetics Presents Positive Results From Cohort 4 of
Treatment with Aficamten Resulted in Significant Improvements in Heart Failure Symptoms and Cardiac Biomarkers in Patients with Non-Obstructive...
89bio Presents New Analysis of Data from Phase 2 ENTRIGUE
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG...
